Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Women's Health Science Journal Research Article 17 min read

The Role of Blood Transfusions in Managing Complications during Pregnancy: A Narrative Review

Obeagu EI* and Obeagu GU*
* Corresponding author
ISSN: 2639-2526  10.23880/whsj-16000211  Received: February 08, 2024  Published: February 22, 2024
 — views
 66 references
PDF
Keywords
Blood Transfusions Pregnancy Complications Maternal Morbidity Obstetric Hemorrhage Anemia Peripartum Transfusion Transfusion Guidelines
Abstract

Pregnancy is a complex physiological state, often accompanied by complications that pose substantial risks to maternal and fetal well-being. Among these complications, obstetric hemorrhage and severe anemia are critical factors contributing to maternal morbidity and mortality. This narrative review explores the pivotal role of blood transfusions in managing these complications during pregnancy. The analysis encompasses the etiologies of obstetric hemorrhage, the impact of severe anemia, and the nuances of blood transfusion therapy. Furthermore, the review evaluates existing transfusion guidelines, emphasizing the need for tailored approaches in the obstetric setting. Special attention is given to transfusion-related complications, shedding light on potential risks and considerations. The article concludes by outlining research gaps and future directions to advance our understanding of blood transfusions in pregnancy, ultimately aiming to optimize maternal outcomes and reduce the burden of complications associated with gestation.

Introduction

Pregnancy, a miraculous journey marked by the creation of life, is nonetheless accompanied by a myriad of challenges that can significantly impact maternal and fetal health. Complications arising during pregnancy, such as obstetric hemorrhage and severe anemia, pose serious threats and necessitate prompt and effective interventions. Among the vital interventions available, blood transfusions play a crucial role in mitigating the risks associated with these complications. This introduction sets the stage for a comprehensive exploration of the role of blood transfusions in managing complications during pregnancy, emphasizing the critical importance of understanding and optimizing transfusion strategies to ensure the well-being of both mother and child [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]. Physiological changes during pregnancy, including an increase in blood volume, cardiac output, and other hemodynamic alterations, creates a unique set of challenges for maternal health. These changes heighten the susceptibility to complications such as obstetric hemorrhage and severe anemia, both of which can lead to adverse outcomes if not managed appropriately. Obstetric hemorrhage, encompassing conditions like postpartum hemorrhage, placental abruption, and uterine rupture, remains a leading cause of maternal mortality globally. Severe anemia, characterized by a depletion of red blood cells and hemoglobin, further compounds the risks, affecting both the mother’s well-being and the developing fetus [16, 17, 18, 19, 20, 21, 22, 23, 24].

Against this backdrop, the role of blood transfusions emerges as pivotal in addressing the complex interplay of factors contributing to maternal morbidity and mortality during pregnancy. Understanding the nuances of when and how to administer blood transfusions becomes paramount, as these interventions have the potential to save lives and enhance the overall health outcomes for both the pregnant woman and her unborn child. The primary objective of this narrative review is to provide a comprehensive exploration of the role of blood transfusions in managing complications during pregnancy.

Obstetric Hemorrhage

Obstetric hemorrhage, a major contributor to maternal morbidity and mortality, encompasses a spectrum of conditions that can lead to excessive bleeding during pregnancy, childbirth, or the postpartum period. Postpartum hemorrhage (PPH), defined as blood loss exceeding 500 ml within 24 hours of delivery, is a primary concern. Placental abruption, occurring when the placenta prematurely detaches from the uterine wall, and uterine rupture, a rare but life-threatening complication, further exemplify the diverse etiologies of obstetric hemorrhage [25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35]. Obstetric hemorrhage poses immediate and severe risks to maternal health, including hypovolemic shock, disseminated intravascular coagulation (DIC), and organ failure. The consequences for the fetus are equally dire, ranging from intrauterine growth restriction to hypoxic- ischemic encephalopathy. The urgency of addressing obstetric hemorrhage requires a multi-faceted approach, with blood transfusions playing a central role in restoring and maintaining adequate perfusion [36, 37, 38, 39, 40, 41, 42, 43, 44, 45].

Blood transfusions in the context of obstetric hemorrhage serve as a critical intervention to replace lost blood volume, correct coagulopathies, and prevent maternal and fetal compromise. Packed red blood cells (PRBCs) are commonly administered to replenish oxygen-carrying capacity, while fresh frozen plasma (FFP) and platelets address coagulation abnormalities. Transfusion triggers, guided by hemodynamic parameters and laboratory values, aim to restore and maintain hemostasis [46]. Current transfusion guidelines emphasize the importance of an individualized approach in obstetric settings. Timely and targeted transfusions are recommended based on clinical assessment, obstetric history, and laboratory parameters. The balance between preventing hypovolemia and avoiding unnecessary transfusions is crucial, with guidelines continually evolving to optimize outcomes. Understanding the dynamic nature of obstetric hemorrhage and tailoring transfusion strategies to the specific needs of each patient is imperative.

Severe Anemia in Pregnancy

Severe anemia during pregnancy is characterized by a significant decrease in red blood cell mass, leading to impaired oxygen-carrying capacity. Physiological changes, including an expansion of plasma volume, can exacerbate anemia by diluting red blood cell concentration. Iron deficiency anemia is the most prevalent form, often attributed to increased iron demands for fetal development and the expansion of maternal blood volume [47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57]. Severe anemia poses substantial risks for both the mother and the developing fetus. Maternally, it can lead to fatigue, weakness, and cardiac strain, while fetal complications may include intrauterine growth restriction, preterm birth, and developmental delays. Identification and management of severe anemia during pregnancy are crucial to prevent these adverse outcomes [58, 59, 60].

Blood transfusions play a pivotal role in managing severe anemia during pregnancy, especially when conservative measures such as iron supplementation prove insufficient or impractical [61]. Transfusion thresholds are often determined by maternal symptoms, hemoglobin levels, and the clinical context. The choice between packed red blood cells (PRBCs) and whole blood depends on the severity of anemia and the clinical presentation of the patient. The benefits of blood transfusions in severe anemia include rapid correction of oxygen-carrying capacity, alleviation of maternal symptoms, and prevention of fetal complications. However, transfusion-related risks, such as transfusion reactions, infection transmission, and alloimmunization, warrant careful consideration. Balancing the potential benefits against these risks is essential in optimizing maternal and fetal outcomes. Guidelines for blood transfusions in cases of severe anemia during pregnancy are evolving to address the unique challenges of the obstetric population. Transfusion triggers, informed by hemoglobin levels, symptoms, and clinical context, guide the initiation of transfusion therapy. Individualized patient care, considering the specific needs and risks of pregnant women, remains a cornerstone of effective management.

Transfusion Guidelines

The management of complications during pregnancy, such as obstetric hemorrhage and severe anemia, relies on evidence-based transfusion guidelines tailored to the unique physiological changes and challenges presented by the obstetric population [62]. These guidelines provide a framework for healthcare providers to make informed decisions regarding the initiation, timing, and type of blood transfusions, aiming to optimize maternal outcomes while minimizing risks. Transfusion guidelines vary among national and international organizations, reflecting evolving evidence and consensus within the medical community [63]. Key organizations, including the World Health Organization (WHO), American College of Obstetricians and Gynecologists (ACOG), and Royal College of Obstetricians and Gynaecologists (RCOG), offer recommendations on transfusion thresholds, blood product selection, and monitoring parameters specific to obstetric complications. The determination of when to initiate blood transfusions, known as transfusion triggers, involves a delicate balance between preventing hypovolemia and avoiding unnecessary transfusions [64]. Hemodynamic parameters, such as blood pressure and heart rate, alongside laboratory values including hemoglobin and coagulation profiles, guide the decision-making process. Individualized care, considering the patient’s clinical presentation and obstetric history, remains paramount. Transfusion guidelines provide insights into the selection of appropriate blood products based on the clinical scenario. Packed red blood cells (PRBCs) address oxygen-carrying capacity, while fresh frozen plasma (FFP) and platelets correct coagulopathies. The judicious use of specific blood components aligns with the goals of therapy, ensuring targeted support for the obstetric patient.

Complications and Risks Associated with Blood Transfusion

While blood transfusions are life-saving interventions, they are not without associated risks and complications. Understanding and mitigating these risks is crucial in optimizing the benefits of transfusion therapy during pregnancy. Immediate transfusion reactions can occur during or shortly after the administration of blood products [65]. These reactions include febrile non-hemolytic reactions, allergic reactions, acute hemolytic reactions, and transfusion- related acute lung injury (TRALI). Healthcare providers must remain vigilant for signs and symptoms, employing pre- transfusion testing and appropriate monitoring to minimize the occurrence of these reactions. Despite rigorous screening measures, the risk of infectious disease transmission remains a concern. Bacterial contamination of blood components, though rare, can lead to serious infections. Viral infections, such as human immunodeficiency virus (HIV), hepatitis B and C, and emerging pathogens, present ongoing challenges. Stringent donor screening and improved testing methodologies aim to mitigate these risks.

Repeated exposure to foreign antigens through transfusions can lead to alloimmunization, wherein the recipient’s immune system produces antibodies against donor blood antigens [66]. In the context of pregnancy, alloimmunization poses the risk of HDFN, a condition where maternal antibodies attack fetal red blood cells, resulting in hemolytic anemia. Strategies to minimize alloimmunization risk include selecting blood products with matched antigens and judicious use of transfusions. Chronic transfusion therapy, often required in severe anemia, can lead to iron overload in pregnant women. Excessive iron deposition in organs can result in complications such as endocrine dysfunction, cardiomyopathy, and hepatic dysfunction. Monitoring and managing iron levels through chelation therapy are essential to prevent these long-term complications. Blood transfusions may modulate the recipient’s immune system, potentially influencing inflammatory responses and immune function. Transfusion-Related Immunomodulatory Complications (TRIM) encompasses a spectrum of immune-related responses, including alterations in the risk of infection, cancer recurrence, and graft-versus-host disease. Understanding the immunomodulatory effects of transfusions is an area of ongoing research. Balancing the potential complications against the life-saving benefits of blood transfusions requires a meticulous, individualized risk-benefit assessment. Healthcare providers must consider the specific clinical context, patient history, and the urgency of the situation. Shared decision-making with the patient and clear communication regarding potential risks and benefits are integral components of safe transfusion practices. To minimize transfusion-related complications, healthcare providers can employ several strategies, including adherence to strict transfusion protocols, comprehensive pre-transfusion testing, and ongoing monitoring of patients post-transfusion. Research efforts should continue to explore innovative technologies and approaches aimed at reducing the risks associated with blood transfusions, particularly in the unique context of pregnancy.

Conclusion

Pregnancy, a miraculous journey of life creation, is not immune to complications that may pose substantial risks to both maternal and fetal well-being. Obstetric hemorrhage and severe anemia, prominent among these complications, necessitate prompt and effective interventions. Blood transfusions emerge as a cornerstone in the management of these challenges, providing life-saving support and addressing the intricate physiological changes inherent to pregnancy. The etiologies of obstetric hemorrhage, encompassing conditions such as postpartum hemorrhage, placental abruption, and uterine rupture, underscore the urgency of intervention. Blood transfusions, guided by evolving transfusion guidelines, play a crucial role in restoring hemostasis and preventing adverse maternal and fetal outcomes. The individualized approach to transfusion triggers, types of blood products, and timing is paramount in optimizing care for pregnant individuals.

Severe anemia, a common complication during pregnancy, further emphasizes the importance of blood transfusions. As iron deficiency anemia impacts maternal and fetal health, judicious use of transfusions becomes essential when conservative measures prove insufficient. The dynamic nature of transfusion guidelines, with a focus on tailored approaches, reflects the ongoing efforts to refine strategies and optimize outcomes in the obstetric setting. The role of blood transfusions in managing complications during pregnancy is pivotal, providing a lifeline to pregnant individuals facing obstetric hemorrhage and severe anemia. A balanced and informed approach, considering the evolving landscape of transfusion medicine, is essential to ensure the well-being of both mother and child during this extraordinary journey of life.

References

  1. May CF (2016) The sacred womb: The evolution of the psyche through pregnancy and childbirth. Pacifica Graduate Institute, USA.
  2. Yarritu DM (2021) Mother Goddess: Archetypal Landscapes in the Lived Experience of Gestational Surrogates. Pacifica Graduate Institute, USA, pp: 1-24.
  3. Terrell PE (2013) Counseling pregnancy, politics, and biomedicine: Empowering discernment. Routledge.
  4. Stormer N (2008) Looking in wonder: Prenatal sublimity and the commonplace “life”. Signs Journal of Women in Culture and Society 33(3): 647-673.
  5. Mazzoni C (2002) Maternal impressions: Pregnancy and childbirth in literature and theory. Cornell University Press.
  6. Obeagu EI, Agreen FC (2023) Anaemia among pregnant women: A review of African pregnant teenagers. J Pub Health Nutri 6(1): 138.
  7. Obeagu EI, Ezimah AC, Obeagu GU (2016) Erythropoietin in the anaemias of pregnancy: A Review. Int J Curr Res Chem Pharm Sci 3(3): 10-18.
  8. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, et al. (2021) Assessment of Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci 9(4): 145-148.
  9. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2): 10-13.
  10. Jakheng SPE, Obeagu EI (2022) Seroprevalence of human immunodeficiency virus based on demographic and risk factors among pregnant women attending clinics in Zaria Metropolis, Nigeria. J Pub Health Nutri 5(6): 127.
  11. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF (2022) Evaluation of Protein C, Protein S and Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of Medicine and Health Sciences 2(2): 1-9.
  12. Obeagu EI, Ikpenwa JN, Chukwueze CM, Obeagu GU (2022) Evaluation of protein C, protein S and fibrinogen of pregnant women in Owerri Metropolis. Madonna University Journal of Medicine and Health Sciences 2(1): 292-298.
  13. Obeagu EI, Obeagu GU, Adepoju OJ (2022) Evaluation of haematological parameters of pregnant women based on age groups in Olorunsogo road area of Ido, Ondo state. J Bio Innov 11(3): 936-941.
  14. Obeagu EI (2022) An update on utilization of antenatal care among pregnant Women in Nigeria. Int J Curr Res Chem Pharm Sci 9(9): 21-26.
  15. Okoroiwu IL, Obeagu EI, Obeagu GU (2022) Determination of clot retraction in preganant women attending antenatal clinic in federal medical centre Owerri, Nigeria. Madonna University Journal of Medicine and Health Sciences 2(2): 91-97.
  16. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ (2021) Evaluation of Changes in Haematological Parameters of Pregnant Women Based on Gestational Age at Olorunsogo Road Area of Ido, Ondo State. Nigeria. Journal of Research in Medical and Dental Science 9(12): 462-464.
  17. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, et al. (2022) ABO blood groups and gestational diabetes among pregnant women attending University of Ilorin Teaching Hospital, Kwara State, Nigeria. International Journal of Research and Reports in Hematology 5(2): 113-21.
  18. Obeagu EI (2023) Gestational Thrombocytopaenia. J Gynecol Women’s Health 25(3): 556163.
  19. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, et al. ( 2022) Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. South Asian Journal of Research in Microbiology 13(2): 26-31.
  20. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, et al. (2021) Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  21. Obeagu EI, Abdirahman BF, Bunu UO, Obeagu GU (2023) Obsterics characteristics that effect the newborn outcomes. Int J Adv Res Biol Sci 10(3): 134-143.
  22. Obeagu EI, Ogunnaya FU (2023) Pregnancy induced Haematological Changes: A Key to Marternal And Child Health. European Journal of Biomedical 10(8): 42-43.
  23. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, et al. (2017) Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research 5(4): 206.
  24. Eze RI, Obeagu EI, Edet FN (2021) Frequency of Rh Antigen C And c among pregnant women in Sub-Urban area in Eastern Nigeria. Madonna Uni J Med Health Sci 1(1): 19-30.
  25. Owen MD, Cassidy AL, Weeks AD (2021) Why are women still dying from obstetric hemorrhage? A narrative review of perspectives from high and low resource settings. Int J Obstet Anesth 46: 102982.
  26. Obeagu EI, Ofodile AC, Okwuanaso CB (2023) A review of urinary tract infections in pregnant women: Risks factors. J Pub Health Nutri 6(1): 137.
  27. Obeagu EI, Obeagu GU, Musiimenta E (2023) Postpartum haemorrhage among pregnant women: Update on risks factors. Int J Curr Res Med Sci 9(2): 14-17.
  28. Obeagu EI, Obeagu GU, Ogunnaya FU (2023) Deep vein thrombosis in pregnancy: A review of prevalence and risk factors. Int J Curr Res Chem Pharm Sci 10(8): 14-21.
  29. Jakheng SP, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(3): 222-229.
  30. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of some haematological parameters in malaria infected pregnant women in Imo state Nigeria. Int J Curr Res Biol Med 3(9): 1-4.
  31. Onyenweaku FC, Amah HC, Obeagu EI, Nwandikor UU, Onwuasoanya UF (2017) Prevalence of asymptomatic bacteriuria and its antibiotic susceptibility pattern in pregnant women attending private ante natal clinics in Umuahia Metropolitan. Int J Curr Res Biol Med 2(2): 13- 23.
  32. Okoroiwu IL, Chinedu Madu JU, Obeagu EI, Vincent CC, Ochiabuto OM, et al. (2021) Evaluation of Iron Status, Haemoglobin and Protein Levels of Pregnant Women in Owerri Metropolis. Journal of Pharmaceutical Research International 33(27A): 36-43.
  33. Obeagu EI, Njar VE, Obeagu GU (2023) Infertility: Prevalence and Consequences. Int J Curr Res Chem Pharm Sci 10(7): 43-50.
  34. Emeka Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of Levels of Some Inflammatory Cytokines in Preeclamptic Women in Owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  35. Obeagu EI, Faduma MH, Uzoma G (2023) Ectopic Pregnancy: A Review. Int J Curr Res Chem Pharm Sci 10(4): 40-44.
  36. Obeagu EI, Gamade SM, Obeagu GU (2023) The Roles of Neutrophils in Pregnancy. Int J Curr Res Med Sci 9(5): 31-35.
  37. Eze R, Obeagu EI, Nwakulite A, Okoroiwu IL, Vincent CC, et al. (2021) Evaluation of Copper Status and Some Red Cell Parameters of Pregnant Women in Enugu State, South Eastern Nigeria. Journal of Pharmaceutical Research International 33(30A): 67-71.
  38. Obeagu EI, Obeagu GU (2023) Molar Pregnancy: Update of Prevalence and Risk Factors. Int J Curr Res Med Sci 9(7): 25-28.
  39. Obeagu EI, Bunu UO (2023) Factors that Influence Unmet Need for Family Planning. International Journal of Current Research in Biology and Medicine 8(1): 23- 27.
  40. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Barriers to Utilization of Maternal Health Services in Southern Senatorial District of Cross Rivers State, Nigeria. Int J Adv Multidiscip Res 4(8): 1-9.
  41. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K (2023) Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth 6(1): 203-211.
  42. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Coagulation Parameters in Malaria Infected Pregnant Women in Imo State, Nigeria. International Journal of Current Research in Medical Sciences 4(9): 41-49.
  43. Obeagu EI, Obeagu GU (2023) Postpartum Haemorrhage among Women Delivering through Spontaneous Vaginal Delivery: Prevalence and Risk Factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  44. Obeagu E, Eze RI, Obeagu EI, Nnatuanya IN, Dara EC (2022) Zinc Level in Apparently Pregnant Women in Urban Area. Madonna University journal of Medicine and Health Sciences 2(1): 134-148.
  45. Ogomaka IA, Obeagu EI (2021) Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs) in Orlu LGA of Imo State, Nigeria. Journal of Pharmaceutical Research International 33(41B): 380- 386.
  46. Shri Janani R Transfusion Practices in Obstetric Emergencies and Its Associated Maternal and Fetal Outcome in a Tertiary Care Centre: An Observational study (Doctoral Dissertation, Thanjavur Medical College, Thanjavur).
  47. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC (2023) Sickle Cell Anaemia: A Gestational Enigma. European Journal of Biomedical and Pharmaceutical Sciences 10(9): 72-75.
  48. Ifeanyi OE, Uzoma OG (2018) A Review on Erythropoietin in Pregnancy. J Gynecol Womens Health 8(3): 1-4.
  49. Ifeanyi OE (2018) A Review on Pregnancy and Haematology. Int J Curr Res Biol Med 3(5): 26-28.
  50. Nwosu DC, Nwanjo HU, Obeagu EI, Ibebuike JE, Ezeama MC et al. (2015) Changes in Liver Enzymes and Lipid Profile of Pregnant Women with Malaria in Owerri, Nigeria. International Journal of Current Research and Academic Review 3(5): 376-383.
  51. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Factors that Influence Women’s Utilization of Primary Health Care Services in Calabar Cros River State, Nigeria. Int J Curr Res Chem Pharm Sci 4(7): 28-33.
  52. Eze R, Ezeah GA, Obeagu EI, Omeje C, Nwakulite A (2021) Evaluation of Iron Status and Some Haematological Parameters of Pregnant Women in Enugu, South Eastern Nigeria. World Journal of Pharmaceutical and Medical Research 7(5): 251-254.
  53. Queen E, Ifeanyi OE, Chinedum OK (2014) Prevalence of Anaemia among Pregnant Women in Braithwaite Memorial Specialist Hospital (BMSH) Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences 9(5): 59-64.
  54. Akandinda M, Obeagu EI, Katonera MT (2022) Non- Governmental Organizations and Women’s Health Empowerment in Uganda: A Review. Asian Research Journal of Gynaecology and Obstetrics 5(1): 263-267.
  55. Jakheng SP, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(1): 222-229.
  56. Gamde MS, Obeagu EI (2023) Iron Deficiency Anaemia: Enemical to Pregnancy. European Journal of Biomedical 10(9): 272-275.
  57. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of Levels of Some Inflammatory Cytokines in Preeclamptic Women in Owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  58. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Studies of Some Haemostatic Variables in Preeclamptic Women in Owerri, Imo State, Nigeria. Journal of Pharmaceutical Research International 33(42B): 39-48.
  59. Obeagu EI, Obeagu GU (2023) Postpartum Haemorrhage among Women Delivering through Spontaneous Vaginal Delivery: Prevalence and Risk Factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  60. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2): 10-13.
  61. Refaai MA, Blumberg N (2013) The Transfusion Dilemma- Weighing the known and Newly Proposed Risks of Blood Transfusions against the Uncertain Benefits. Best Pract Res Clin Anaesthesiol 27(1): 17-35.
  62. Shaylor R, Weiniger CF, Austin N, Tzabazis A, Shander A, et al. (2017) National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review. Anesth Analg 124(1): 216-232.
  63. Farmakis D, Porter J, Taher A, Cappellini MD, Angastiniotis M, et al. (2022) 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-Dependent Thalassemia. Hemasphere 6(8): e732.
  64. Tomic Mahecic T, Dunser M, Meier J (2020) RBC Transfusion Triggers: Is There Anything New? Transfus Med Hemother 47(5): 361-368.
  65. Sahu S, Verma A (2014) Adverse Event Related to Blood Transfusion. Indian J Anaesth 58(5): 543-551.
  66. Hart S, Cserti Gazdewich CM, McCluskey SA (2015) Red Cell Transfusion and the Immune System. Anaesthesia 70(Suppl 1): 38-45: e13-e16.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{obeagu2024,
  title   = {The Role of Blood Transfusions in Managing Complications
during Pregnancy: A Narrative Review},
  author  = {Obeagu EI* and Obeagu GU},
  journal = {Women\'s Health Science Journal},
  year    = {2024},
  volume  = {8},
  number  = {1},
  doi     = {10.23880/whsj-16000211}
}
Obeagu EI* and Obeagu GU (2024). The Role of Blood Transfusions in Managing Complications
during Pregnancy: A Narrative Review. Women's Health Science Journal, 8(1). https://doi.org/10.23880/whsj-16000211
TY  - JOUR
TI  - The Role of Blood Transfusions in Managing Complications
during Pregnancy: A Narrative Review
AU  - Obeagu EI* and Obeagu GU
JO  - Women's Health Science Journal
PY  - 2024
VL  - 8
IS  - 1
DO  - 10.23880/whsj-16000211
ER  -